Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study

Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study

Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare the risk of stroke/systemic embolism (S/SE) and major bleeding (MB) between patients treated with reduced-dose NOACs and those t...

Full description

Bibliographic Details
Main Authors: Sola Han, Young-Hoon Kim, Myung-Yong Lee, Oh Young Bang, Sung-Won Jang, Seongwook Han, Yoo-Jung Park, Seongsik Kang, Young Keun On, Hae Sun Suh
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
anticoagulants
atrial fibrillation
NOAC
stroke
systemic embolism
warfarin
Online Access:https://www.mdpi.com/2077-0383/10/17/3918

Internet

https://www.mdpi.com/2077-0383/10/17/3918

Similar Items